相关实验视频
Updated: Jan 6, 2026

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.7K
PPARs在动脉样硬化中的明确作用
Guofang Wang1, Yu Yan1, Qian Sun1
1Key Laboratory of Exercise and Health Sciences (Shanghai University of Sport), School of Exercise and Health, Ministry of Education, China (G.W., Y.Y., Q.S., L.C., L.L.).
Arteriosclerosis, thrombosis, and vascular biology
|November 20, 2025
概括
过氧体增殖器激活受体 (PPAR) 在动脉样硬化中起着复杂的作用,影响脂质代谢和炎症. 了解这些核受体为新的心血管疾病治疗提供了潜力.
科学领域:
- 心血管科学 心血管科学
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 动脉样硬化是心血管疾病的主要原因,其特点是脂质问题,内皮功能障碍和炎症.
- 过氧体增殖器激活受体 (PPAR) 是调节新陈代谢和炎症的核受体.
- PPAR对不同组织和细胞类型的动脉样硬化有着不同的,取决于环境的影响.
研究的目的:
- 审查PPARs在动脉样硬化发展和治疗中的功能和分子机制.
- 专注于PPAR在脂质代谢,炎症和血管重塑中的作用.
- 评估针对PPAR的治疗策略,并确定研究缺口.
主要方法:
- 关于PPARs和动脉样硬化的研究的文献综述.
- 对PPAR功能背后的分子机制的分析.
- 对PPAR向疗法的临床前和临床数据的评估.
主要成果:
- PPARs显著影响脂质新陈代谢,降低异构脂质水平.
- PPAR激活调节炎症通路,减少免疫细胞在血管中的透.
- PPARs影响血管重塑过程,影响斑块的稳定性和进展.
结论:
- PPARs是动脉样硬化中的关键调节剂,具有多方面的作用.
- 准PPARs为心血管疾病提供了一个有前途的治疗途径.
- 需要进一步的研究,以充分阐明PPAR功能和优化治疗策略.
相关概念视频
Peripheral Artery Disease I: Introduction
275
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
275
Atherosclerosis I: Introduction
738
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
738
Atherosclerosis III: Management
290
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
Coronary Artery Disease I: Introduction
843
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
843
Coronary Artery Disease II: Pathophysiology
332
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
332
Inflammation
61.4K
Overview
61.4K

